Displaying 32 (all) recruiting clinical trials.
-
TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE BREAST CANCER
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving ... -
Heart Attack Research Program (HARP)
The Heart Attack Research Program (HARP) is a multi-discipline and mutli-center study that incorporates clinical and basic science and population health to investigate mechanisms of ... -
CivaTech Oncology:Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet
This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration ... -
Site for WUH: Effect of storage on breast milk cytokines in premature infants in the first 4 weeks after birth
Site for The Objective of this study is to evaluate the effect of storage of freshly expressed breast milk at different temperatures (Room air, 4 ... -
Site for HARP (Heart Attack Research Program) - NYU PI: Harmony Reynolds MD NYU Winthrop PI Kevin Marzo M.D.
Site for HARP (Heart Attack Research Program) - NYU PI: Harmony Reynolds, MD NYU Winthrop PI Kevin Marzo -
Biomarkers for preterm births using non-invasive samples
Preterm delivery is a leading cause of neonatal mortality and continues to be a major public health concern. Although some pregnant women will present with ... -
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly
Fetal complete (i.e., third degree) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally ... -
The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD) A Double-Blinded Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib
CompassHER2 RD (A011801) is a randomized trial in patients with residual disease after a predefined course of neoadjuvant HER2-directed treatment. While CompassHER2 RD allows entry ... -
Reach Out Stay Strong Essentials for mothers of newborns (ROSE) Adaptation for Chinese American mothers
We are conducting a cultural adaptation and pilot study of a postpartum depression prevention intervention among pregnant Chinese American women. Once we establish feasibility and ... -
Prospective NIPT Sample Collection Protocol
This study is being done to develop and validate an investigational noninvasive prenatal test to determine chromosomal anomalies. Pregnant women >10 weeks gestation with positive ...